KR102588606B1 - Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP) - Google Patents

Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP) Download PDF

Info

Publication number
KR102588606B1
KR102588606B1 KR1020230018937A KR20230018937A KR102588606B1 KR 102588606 B1 KR102588606 B1 KR 102588606B1 KR 1020230018937 A KR1020230018937 A KR 1020230018937A KR 20230018937 A KR20230018937 A KR 20230018937A KR 102588606 B1 KR102588606 B1 KR 102588606B1
Authority
KR
South Korea
Prior art keywords
kctc
culture
pga
bacillus subtilis
saccharomyces cerevisiae
Prior art date
Application number
KR1020230018937A
Other languages
Korean (ko)
Inventor
이재섭
배준태
장준환
김희식
김나리
이지연
문소현
권승범
Original Assignee
주식회사 제이투케이바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제이투케이바이오 filed Critical 주식회사 제이투케이바이오
Priority to KR1020230018937A priority Critical patent/KR102588606B1/en
Application granted granted Critical
Publication of KR102588606B1 publication Critical patent/KR102588606B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/165Yeast isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/14Glutamic acid; Glutamine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • C12R2001/125Bacillus subtilis ; Hay bacillus; Grass bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 혼합배양을 통해 우수한 보습, 염증완화, 홍반개선 및 피부진정 효과를 나타내는 화장료 조성물을 제조할 수 있다. 또한, 본 발명은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 혼합배양을 통해 악취 발생이 현저히 줄어든 상태로 γ-PGA를 고수율로 생산할 수 있다.The present invention is a mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast, showing excellent moisturizing, inflammation alleviating, erythema improvement and skin soothing effects. A cosmetic composition can be manufactured. In addition, the present invention purifies γ-PGA with significantly reduced odor through mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast. It can be produced with high yield.

Description

녹차꽃에서 분리된 사카로마이세스 세레비지애 J2K-23(KCTC 13695BP) 및 누룩에서 분리된 바실러스 서브틸리스 J2K-51(KCTC 14053BP)의 혼합배양을 통한 화장료 조성물의 제조 및 폴리감마글루탐산의 생산 {Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)}Preparation of cosmetic compositions and production of poly-gamma-glutamic acid through mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast {Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)}

본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 J2K-23(KCTC 13695BP) 및 누룩에서 분리된 바실러스 서브틸리스 J2K-51(KCTC 14053BP)의 혼합배양을 통한 화장료 조성물의 제조 및 폴리감마글루탐산의 생산에 관한 것으로, 우수한 보습, 염증완화, 홍반개선 및 피부진정 효과를 나타내는 화장료 조성물을 제조할 수 있고, 악취 발생이 현저히 줄어든 상태로 화장품에 사용될 수 있는 γ-PGA를 고수율로 생산할 수 있다.The present invention relates to the preparation of a cosmetic composition through mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast and polygamma Regarding the production of glutamic acid, it is possible to manufacture cosmetic compositions that exhibit excellent moisturizing, inflammation relief, erythema improvement, and skin soothing effects, and to produce γ-PGA that can be used in cosmetics in high yield with significantly reduced odor generation. there is.

최근에는 환경이나 생활습관의 변화 및 각종 스트레스와 공해물질로 인한 환경오염과 화장습관에 따른 잦은 세안 및 노화에 따른 자연적인 피부 퇴화 등의 원인으로 인해 피부가 건조해지고 표면이 거칠게 되며 윤기를 잃어 칙칙하게 보이는 등의 현상이 빈번하게 발생되면서 피부건강에 관한 문제는 그 중요성이 점점 증대되고 있다.Recently, due to changes in the environment or lifestyle, environmental pollution due to various stresses and pollutants, frequent washing of the face due to makeup habits, and natural skin deterioration due to aging, the skin becomes dry, the surface becomes rough, and the skin loses its luster and becomes dull. As phenomena such as looking hazy occur frequently, the importance of skin health issues is increasing.

피부 스트레스로부터 피부 건강을 유지하는 방법으로, 피부 수분의 건조 방지 및 각질층에서의 수분 보유능 향상을 위한 보습용 소재 개발에 많은 공을 들여 왔다.As a way to maintain skin health from skin stress, much effort has been put into developing moisturizing materials to prevent drying of skin moisture and improve moisture retention in the stratum corneum.

건조 피부가 형성되면 피부 표면의 방어기능(barrier function)이 소실되고 외부로부터의 자극물이나 알러젠의 피부 침입이 용이할 뿐만 아니라, 이러한 침입물에 대하여 피부가 거부 반응을 일으키기 때문이다. 피부의 거부반응은 표층 성분의 대다수를 구성하는 케라티노사이트(keratinocyte)라는 각화 세포가 소수의 랑게르한스(Langerhans) 및 멜라노사이트(melanocyte) 등의 세포를 활성화시킴으로써, 이들 세포가 생산 및 방출하는 사이토카인(cytokine)에 의한 염증 현상으로 나타난다.When dry skin is formed, the barrier function of the skin surface is lost and external irritants or allergens not only easily invade the skin, but also cause a rejection reaction of the skin against these invaders. The rejection reaction of the skin is caused by keratinocytes called keratinocytes, which make up the majority of the surface layer components, activating a small number of cells such as Langerhans and melanocytes, and cytokines produced and released by these cells. It appears as an inflammatory phenomenon caused by cytokines.

상기 사이토카인은 염증 세포를 불러모으는 작용을 하고, 특히 피부의 구성 세포를 자극시켜 피부 상층을 중심으로 한 염증 반응을 일으키고 습진 반응을 형성하는데, 이를 비알러지성 피부병이라고 한다. The cytokine acts to recruit inflammatory cells, and in particular stimulates the skin's constituent cells, causing an inflammatory reaction centered on the upper layer of the skin and forming an eczema reaction, which is called non-allergic skin disease.

따라서, 피부진정 및 보습 효과가 강력한 물질은 항염효과까지 확장될 수 있는 잠재적 가능성이 있고, 반대로 항염효과가 있는 물질이 피부진정 및 피부보습에도 효과가 있을 것으로 예측할 수 있으나 실질적으로 이와 같은 천연소재를 찾는 것은 매우 어려운 과정을 거쳐야 하는 문제점이 있었다.Therefore, substances with strong skin soothing and moisturizing effects have the potential to extend to anti-inflammatory effects, and conversely, substances with anti-inflammatory effects can be predicted to be effective in skin soothing and skin moisturizing, but in reality, such natural materials There was a problem in that it had to be a very difficult process to find.

한편, 폴리감마글루탐산 (poly-gamma-glutamic acid; γ-PGA)은 청국장에 존재하는 바실러스 서브틸리스 (Bacillus subtilis) 유래의 생체 고분자 물질이다. 전통적으로 청국장을 통해 섭취해 온 폴리감마글루탐산은 안전성, 수용성, 비독성 및 생분해성이 입증된 물질로서, 전염증성 사이토카인 분비 촉진 및 TLR4 (toll-like receptor 4)를 통한 항원 제시 세포 (antigen presenting cell; APC)의 활성화 등 선천성 면역 반응을 유도하는 것으로 알려져 있다. 또한, Th1 면역 반응을 촉진하여 세포 독성 T 림프구 (cytotoxic T lymphcyte; CTL) 활성과 같은 세포성 면역 반응을 유도하는 것으로도 알려져 있다. 이와 같은 우수한 기능이 있는 폴리감마글루탐산 (poly-gamma-glutamic acid; γ-PGA)은 화장품에 피부보습 및 탄력 증진의 목적으로 널리 사용되고 있다. Meanwhile, poly-gamma-glutamic acid (γ-PGA) is a biopolymer derived from Bacillus subtilis , which is present in Cheonggukjang. Poly-gamma-glutamic acid, which has been traditionally consumed through Cheonggukjang, is a substance that has been proven to be safe, water-soluble, non-toxic, and biodegradable. It promotes the secretion of pro-inflammatory cytokines and promotes antigen presenting cells through TLR4 (toll-like receptor 4). It is known to induce innate immune responses, such as activation of APC). In addition, it is known to promote Th1 immune response and induce cellular immune responses such as cytotoxic T lymphocyte (CTL) activity. Poly-gamma-glutamic acid (γ-PGA), which has such excellent functions, is widely used in cosmetics for the purpose of moisturizing the skin and improving elasticity.

대한민국 특허등록 제10-1824179호(2018.01.25.)Republic of Korea Patent Registration No. 10-1824179 (2018.01.25.) 대한민국 특허등록 제10-2293081호(2021.08.18.)Republic of Korea Patent Registration No. 10-2293081 (2021.08.18.) 대한민국 특허등록 제10-0517114호(2005.09.16)Republic of Korea Patent Registration No. 10-0517114 (2005.09.16)

본 발명의 목적은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)을 이용한 화장료 조성물 및 화장품 원료로 사용될 수 있는 γ-PGA의 생산방법을 개발하여 제공하고자 한다. The purpose of the present invention is to produce a cosmetic composition using Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast and a method for producing γ-PGA that can be used as a cosmetic raw material. We would like to develop and provide.

본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하여 수득되는 배양액을 함유하는 것을 특징으로 하는 피부자극 완화용 화장료 조성물을 제공한다. 이때, 상기 화장료 조성물은, 바람직하게 피부보습능, 염증완화능, 홍반개선능 및 피부진정능 중 선택되는 어느 하나의 효능이 더 있는 것일 수 있다. The present invention is a mixture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Provided is a cosmetic composition for alleviating skin irritation, characterized in that it contains a culture solution obtained by culturing. At this time, the cosmetic composition may preferably have any one effect selected from skin moisturizing effect, inflammation alleviating effect, erythema improving effect, and skin soothing effect.

한편, 본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하는 것을 특징으로 하는 γ-PGA의 생산방법을 제공한다. 이때, 상기 γ-PGA의 생산방법은, 바람직하게 배양 악취가 저감된 것일 수 있다. Meanwhile, the present invention relates to the Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and the Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Provides a method for producing γ-PGA, characterized by mixed culture. At this time, the method for producing γ-PGA may preferably have reduced culture odor.

또한, 본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하는 것을 특징으로 하는 γ-PGA 함유 배양액의 제조방법을 제공한다. 이때, 상기 γ-PGA 함유 배양액의 제조방법은, 바람직하게 배양 악취가 저감된 것일 수 있다. In addition, the present invention relates to the Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and the Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Provides a method for producing a culture medium containing γ-PGA, characterized in that mixed culture. At this time, the method for producing the γ-PGA-containing culture medium may preferably have reduced culture odor.

본 발명은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 혼합배양을 통해 우수한 보습, 염증완화, 홍반개선 및 피부진정 효과를 나타내는 화장료 조성물을 제조할 수 있다. The present invention is a mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast, showing excellent moisturizing, inflammation alleviating, erythema improvement and skin soothing effects. A cosmetic composition can be manufactured.

또한, 본 발명은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 혼합배양을 통해 γ-PGA를 고수율로 생산할 수 있었으며, 특유의 악취가 감소되어 정제공정을 단순화 할 수 있다. 이와 같이 생산된 γ-PGA는 화장품에 피부보습 및 탄력 증진의 목적으로 사용될 수 있다. In addition, the present invention was able to produce γ-PGA in high yield through mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast. The odor is reduced and the purification process can be simplified. γ-PGA produced in this way can be used in cosmetics for the purpose of moisturizing the skin and improving elasticity.

도 1은 본 발명의 제조예 3을 통해 제조된 배양물의 Aquaporin-3 발현 효과를 측정하여 나타낸 것이다.
도 2는 본 발명의 제조예 3을 통해 제조된 배양물의 COX-2의 생성저해 효과를 측정하여 나타낸 것이다.
도 3은 본 발명의 실시예 1을 통해 제조된 화장료 조성물의 외부 자극(SLS)에 의한 피부 진정(붉은기 완화, 자극 완화) 효과를 평가하여 나타낸 것이다.
도 4는 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23의 동정결과를 확인할 수 있는 보고서이다.
도 5는 바실러스 서브틸리스(Bacillus subtilis) J2K-51의 동정 결과를 확인할 수 있는 보고서이다.
Figure 1 shows the measured effect of Aquaporin-3 expression in the culture prepared through Preparation Example 3 of the present invention.
Figure 2 shows the measured effect of inhibiting COX-2 production in the culture prepared through Preparation Example 3 of the present invention.
Figure 3 shows an evaluation of the skin soothing (relieving redness, alleviating irritation) effect caused by external stimulation (SLS) of the cosmetic composition prepared through Example 1 of the present invention.
Figure 4 is a report confirming the identification results of Saccharomyces cerevisiae J2K-23.
Figure 5 is a report confirming the identification results of Bacillus subtilis J2K-51.

본 발명은 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 제공한다. 또한, 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주를 제공한다. 본 발명에서 분리한 상기 균주를 배양할 경우 피부자극 완화효능이 있는 배양액을 얻을 수 있다. The present invention provides Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Additionally, Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers is provided. When cultivating the strain isolated in the present invention, a culture medium with skin irritation alleviating effect can be obtained.

또한, 본 발명은 상기 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주의 배양액을 함유하는 화장료 조성물을 제공한다. 또한, 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주의 배양액을 함유하는 화장료 조성물을 제공한다. 본 발명의 화장료 조성물은 피부자극에 대해 자극 완화 효능이 있다. 또한, 피부보습능, 염증완화능, 홍반개선능 및 피부진정능 중 선택되는 어느 하나 이상의 효능이 더 발휘되기도 한다. Additionally, the present invention provides a cosmetic composition containing a culture medium of the Bacillus subtilis J2K-51 (KCTC 14053BP) strain. Additionally, a cosmetic composition containing a culture medium of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers is provided. The cosmetic composition of the present invention has an irritation alleviating effect on skin irritation. In addition, one or more effects selected from skin moisturizing effect, inflammation alleviating effect, erythema improving effect, and skin soothing effect may be further exerted.

본 발명에서는 바람직하게 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주와 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주를 혼합배양하여 수득되는 배양액을 사용하는 것이 좋다. 이때, 상기 혼합배양하여 수득되는 배양액은 상기 두 균주를 동시 배양하는 방식으로 혼합배양하는 것이 바람직하다. In the present invention , Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast and Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers. It is recommended to use a culture medium obtained by mixed culture. At this time, it is preferable that the culture medium obtained through the mixed culture is mixed cultured by simultaneously culturing the two strains.

다만, 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주를 배지에 접종하여 1차 배양한 후 배지를 멸균하고, 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 추가로 접종하고 2차 배양하는 방식으로 혼합배양을 수행할 수도 있다. 이와 같이 하나의 배치(batch) 내에서 1차, 2차 배양을 상호 분리해서 수행할 경우, 상기 균주의 혼합배양에 따른 일부 균의 생육 저해와 같은 문제를 해소할 수 있고, 하나의 배치를 사용함에 따라 생산원가를 낮출 수 있는 장점이 있다. However, the Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers was inoculated into the medium and cultured for the first time, and then the medium was sterilized, and Bacillus subtilis isolated from yeast ( Mixed culture can also be performed by additionally inoculating Bacillus subtilis J2K-51 (KCTC 14053BP) strain and performing secondary culture. In this way, when primary and secondary cultures are performed separately from each other within one batch, problems such as inhibition of growth of some bacteria due to mixed culture of the above strains can be resolved, and one batch is used. It has the advantage of lowering production costs.

본 발명에 따른 화장료 조성물은 피부자극 완화의 효과를 나타내는데, 유사한 효과로서, 피부염증완화, 피부홍반개선 및 피부진정 효과를 나타내는 것으로 해석할 수도 있다. The cosmetic composition according to the present invention exhibits the effect of relieving skin irritation, and as similar effects, it can be interpreted as showing the effect of alleviating skin inflammation, improving skin erythema, and soothing the skin.

본 발명의 화장료 조성물에서, 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP) 및 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 혼합 배양액은 바람직하게 0.0005 내지 30 중량%의 비율로 화장료 조성물에 첨가될 수 있다. In the cosmetic composition of the present invention, the mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast is preferably used as a cosmetic at a ratio of 0.0005 to 30% by weight. may be added to the composition.

한편, 본 발명의 화장료 조성물은 특별한 것으로 한정되는 것은 아니고, 일 예로, 용액, 외용연고, 크림, 폼, 영양화장수, 유연화장수, 팩, 유연수, 유액, 메이크업베이스, 에센스, 액체 세정료, 입욕제, 선 스크린크림, 선오일, 현탁액, 유탁액, 페이스트, 겔, 로션, 파우더, 계면활성제-함유 클렌징 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 패치 및 스프레이로 이루어진 그룹에서 선택된 하나의 제형일 수 있다. 또한, 각 제형을 이루기 위하여 통상적으로 해당분야 에서 사용되는 첨가제를 더욱 포함할 수 있다.Meanwhile, the cosmetic composition of the present invention is not limited to a specific one, and examples include solutions, external ointments, creams, foams, nourishing lotions, softening lotions, packs, softening water, emulsions, makeup bases, essences, liquid cleansers, bath additives, Can be a formulation selected from the group consisting of sunscreen creams, sun oils, suspensions, emulsions, pastes, gels, lotions, powders, surfactant-containing cleansing oils, powder foundations, emulsion foundations, wax foundations, patches and sprays. there is. In addition, to achieve each formulation, additives commonly used in the relevant field may be further included.

또한, 본 발명의 화장료 조성물은 일반 피부 화장료에 배합되는 화장품학적으로 허용 가능한 담체를 1종 이상 추가로 포함할 수 있으며, 통상의 성분으로 예를 들면 유분, 물, 계면활성제, 보습제, 저급 알콜, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나 이에 제한되는 것은 아니며, 본 발명의 화장료 조성물에 포함되는 화장품학적으로 허용가능한 담체는 제형에 따라 다양하게 적용할 수 있다.In addition, the cosmetic composition of the present invention may additionally contain one or more cosmetically acceptable carriers that are blended with general skin cosmetics, and common ingredients include, for example, oil, water, surfactant, moisturizer, lower alcohol, Thickeners, chelating agents, pigments, preservatives, fragrances, etc. can be appropriately mixed, but are not limited thereto, and the cosmetically acceptable carrier included in the cosmetic composition of the present invention can be applied in various ways depending on the formulation.

한편, 본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하는 것을 특징으로 하는 γ-PGA의 생산방법을 제공한다. Meanwhile, the present invention relates to the Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and the Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Provides a method for producing γ-PGA, characterized by mixed culture.

또한, 본 발명은 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하는 것을 특징으로 하는 γ-PGA 함유 배양액의 제조방법을 제공한다.In addition, the present invention relates to the Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and the Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Provides a method for producing a culture medium containing γ-PGA, characterized in that mixed culture.

상기 본 발명의 γ-PGA의 생산방법 및 γ-PGA 함유 배양액의 제조방법은, 배지 성분으로 Yeast Extract(Y.E) 대신 Malt Extract(M.E)를 사용하고, J2K-23 균주 및 J2K-51 균주의 혼합배양을 통해 γ-PGA를 고수율로 생산할 수 있었으며, 특유의 악취가 감소되어 정제공정을 단순화 할 수 있었다. 악취 제거를 위해서는 일반적으로 용매침전 후 침전물을 회수, 재용해하는 부수적인 공정이 필요한데, 본 발명에서는 이러한 부수적인 공정이 불필요하여 경제적이고, 친환경적인 것이다. The method for producing γ-PGA and the method for producing a culture medium containing γ-PGA of the present invention uses Malt Extract (M.E) instead of Yeast Extract (Y.E) as a medium component and mixes J2K-23 strain and J2K-51 strain. Through culture, γ-PGA could be produced in high yield, and the purification process could be simplified by reducing the unique odor. In order to remove odor, an additional process of recovering and re-dissolving the precipitate after solvent precipitation is generally required, but in the present invention, this additional process is unnecessary, making it economical and environmentally friendly.

본 발명의 γ-PGA의 생산방법 및 γ-PGA 함유 배양액의 제조방법에 있어서, 배양 배지는, 바람직하게 포도당 10~30g/L, Malt Extract 1~9g/L, 소듐글루타메이트 25~75g/L를 포함하는 것이 좋고, 더욱 바람직하게는 제이인산칼륨 0.1~0.9g/L, 황산마그네슘7수화물 0.05~0.15g/L를 더 포함하는 것이 좋다. In the method for producing γ-PGA and the method for producing a γ-PGA-containing culture medium of the present invention, the culture medium preferably contains 10 to 30 g/L of glucose, 1 to 9 g/L of Malt Extract, and 25 to 75 g/L of sodium glutamate. It is good to include, more preferably, 0.1 to 0.9 g/L of potassium phosphate and 0.05 to 0.15 g/L of magnesium sulfate heptahydrate.

이하, 본 발명의 내용에 대해 하기 제조예, 실시예 및 실험예를 통해 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 제조예, 실시예 및 실험예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다. Hereinafter, the contents of the present invention will be described in more detail through the following production examples, examples, and experimental examples. However, the scope of the present invention is not limited to the following manufacturing examples, examples, and experimental examples, and includes modifications of the technical idea equivalent thereto.

<제조예 1> 녹차꽃에서 <Production Example 1> From green tea flowers Saccharomyces cerevisiaeSaccharomyces cerevisiae J2K-23(KCTC 13695BP)의 분리 Isolation of J2K-23 (KCTC 13695BP)

제주도 올티스 지역의 녹차밭에서 채취한 녹차꽃을 균주 분리 시료로 사용하였다. 상기 시료를 멸균 생리식염수에 현탁 및 희석하고, 이를 0.1 mL씩 취해 Difco Yeast Extract Peptone Dextrose(YPD) agar 배지에 도말하였다. 이후, 플레이트를 30℃의 항온배양기에서 3일 동안 배양하였다. 생성된 각각의 콜로니를 YPD 플레이트에 획선 접종하였고, 30℃에서 3일 동안 배양하여 미색의 집락을 보이는 콜로니를 취하는 방법을 통해 제주 올티스 지역의 녹차꽃으로부터 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23를 분리하였다.Green tea flowers collected from green tea fields in the Oltis area of Jeju Island were used as strain isolation samples. The sample was suspended and diluted in sterile saline solution, and 0.1 mL of it was taken and spread on Difco Yeast Extract Peptone Dextrose (YPD) agar medium. Afterwards, the plate was cultured in a constant temperature incubator at 30°C for 3 days. Each resulting colony was inoculated onto a YPD plate, cultured at 30°C for 3 days, and colonies showing off-white colonies were harvested to inoculate Saccharomyces cerevisiae from green tea flowers in the Oltis region of Jeju. ) J2K-23 was isolated.

분리한 균주에 대해 18S rRNA 핵산서열 분석을 하였고 그 결과 서열번호 1에 기재된 것과 같은 핵산서열을 확인할 수 있었다. 이를 통해, 분리 균주를 Saccharomyces cerevisiae로 동정할 수 있었다. 18S rRNA nucleic acid sequence analysis was performed on the isolated strain, and as a result, the same nucleic acid sequence as described in SEQ ID NO: 1 was confirmed. Through this, the isolated strain could be identified as Saccharomyces cerevisiae .

도 4는 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23의 동정결과를 확인할 수 있는 보고서이다. Figure 4 is a report confirming the identification results of Saccharomyces cerevisiae J2K-23.

<제조예 2> 누룩에서 <Production Example 2> From yeast Bacillus subtilisBacillus subtilis J2K-51(KCTC 14053BP)의 분리 Isolation of J2K-51 (KCTC 14053BP)

제주도 지역의 누룩을 균주 분리 시료로 사용하였다. 상기 시료를 멸균 생리식염수에 현탁 및 희석하고, 이를 0.1 mL씩 취해 Millipore Tryptic Soy Agar(TSA) 배지에 도말하였다. 이후, 플레이트를 35℃의 항온배양기에서 1일 동안 배양하였다. 생성된 각각의 콜로니를 TSA 플레이트에 획선 접종하였고, 35℃에서 2일 동안 배양하여 미색의 집락을 보이는 콜로니를 취하는 방법을 통해 제주도 누룩으로부터 바실러스 서브틸리스(Bacillus subtilis) J2K-51를 분리하였다.Nuruk from the Jeju Island region was used as a strain isolation sample. The sample was suspended and diluted in sterile saline solution, and 0.1 mL of it was taken and spread on Millipore Tryptic Soy Agar (TSA) medium. Afterwards, the plate was cultured in an incubator at 35°C for 1 day. Each resulting colony was inoculated onto a TSA plate, and Bacillus subtilis J2K-51 was isolated from Jeju Island yeast by culturing at 35°C for 2 days and collecting off-white colonies.

분리한 균주에 대해 16S rRNA 핵산서열 분석을 하였고 그 결과 서열번호 2에 기재된 것과 같은 핵산서열을 확인할 수 있었다. 이를 통해, 분리 균주를 Bacillus subtilis로 동정할 수 있었다. 16S rRNA nucleic acid sequence analysis was performed on the isolated strain, and as a result, the same nucleic acid sequence as described in SEQ ID NO: 2 was confirmed. Through this, the isolated strain could be identified as Bacillus subtilis .

도 5는 바실러스 서브틸리스(Bacillus subtilis) J2K-51의 동정 결과를 확인할 수 있는 보고서이다. Figure 5 is a report confirming the identification results of Bacillus subtilis J2K-51.

<제조예 3> <Production Example 3> Saccharomyces cerevisiaeSaccharomyces cerevisiae J2K-23 (KCTC 13695BP)와 J2K-23 (KCTC 13695BP) and Bacillus subtilisBacillus subtilis J2K-51 (KCTC 14053BP)로 혼합배양된 배양물의 제조 Preparation of mixed cultures with J2K-51 (KCTC 14053BP)

배지로 글루코스 (Glucose) 2%(w/v), 맥아 추출물(Malt Extract) 0.5%(w/v), 소듐글루타메이트(Sodium glutamate) 5.0%(w/v) 제이인산칼륨(K2HPO4) 0.05%(w/v), 황산마그네슘(MgSO4) 0.01%(w/v)을 포함한 배지를 사용하되, 상기의 배지 성분을 용해 후 121℃에서 20분간 멸균을 진행한 뒤 냉각하고, 냉각된 배지에 상기 제조예 1 내지 2에서 분리한 균주를 순차적으로 동시에 접종하고 33℃의 온도에서 회전수 120rpm의 조건으로 50시간 동안 배양하여 Saccharomyces cerevisiae J2K-23 (KCTC 13695BP)와 Bacillus subtilis J2K-51 (KCTC 14053BP)로 혼합 배양된 배양물을 제조하였다.The medium contains 2% (w/v) glucose, 0.5% (w/v) malt extract, 5.0% (w/v) sodium glutamate, and potassium phosphate (K 2 HPO 4 ). Use a medium containing 0.05% (w/v) and 0.01% (w/v) of magnesium sulfate (MgSO 4 ). After dissolving the above medium components, sterilize at 121°C for 20 minutes, cool, and cool. The strains isolated in Preparation Examples 1 and 2 were sequentially and simultaneously inoculated into the medium and cultured for 50 hours at a temperature of 33°C and a rotation speed of 120 rpm to inoculate Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) and Bacillus subtilis J2K-51 ( A mixed culture was prepared with KCTC 14053BP).

<실시예 1> 본 발명 균주들을 이용한 화장료 조성물의 제조<Example 1> Preparation of cosmetic composition using strains of the present invention

정제수에 상기 제조예 3을 통해 제조된 Saccharomyces cerevisiae J2K-23 (KCTC 13695BP)와 Bacillus subtilis J2K-51 (KCTC 14053BP)로 혼합 배양된 배양물이 3 중량% 함유되도록 하여 화장료 조성물(Metabiome HK-503)을 제조하였다.A cosmetic composition (Metabiome HK-503) was prepared by containing 3% by weight of a mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) and Bacillus subtilis J2K-51 (KCTC 14053BP) prepared in Preparation Example 3 in purified water. was manufactured.

<실험예 1> 세포 생존률 확인 <Experimental Example 1> Confirmation of cell viability

세포 생존률(cell viability)의 확인은 MTT(3-[4,5-dimethylthiazol-2-yl]-2,5-diphinyltetrazolium bromide) assay법을 이용하여 분석하였다. 96-well plate에 5×104cell/ml(HaCaT cells) 의 세포를 분주하고 시료를 처리하고 37℃에서 각 면역실험 조건에 상응하는 배양시간 동안 CO2 배양기에서 배양하였다. 이후 10 ㎕ MTT 용액(stock concentration : 5 mg/ml)을 첨가하고 3시간 동안 추가반응을 유도하였다. 반응 종료 및 포르마잔 crystal 용해를 위해 각 well에 100㎕ MTT stopping solution (10% Sodium dodecyl sulfate in 0.01M HCl)을 추가적으로 첨가하였다. 세포 생존률은 MTT가 포르마잔으로 환원된 양을 570 nm에서 흡광도를 측정하여 얻어진 OD 값을 통해 산출하였다.Cell viability was confirmed using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphinyltetrazolium bromide) assay. Cells of 5×10 4 cells/ml (HaCaT cells) were dispensed into a 96-well plate, samples were processed, and cultured in a CO 2 incubator at 37°C for an incubation time corresponding to each immunoexperiment condition. Afterwards, 10 ㎕ MTT solution (stock concentration: 5 mg/ml) was added and further reaction was induced for 3 hours. To terminate the reaction and dissolve the formazan crystals, 100㎕ MTT stopping solution (10% Sodium dodecyl sulfate in 0.01M HCl) was additionally added to each well. Cell viability was calculated through the OD value obtained by measuring the absorbance at 570 nm of the amount of MTT reduced to formazan.

상기 제조예 3을 통해 제조된 배양물의 인간 각질형성세포(keratinocyte)인 HaCaT 세포 및 쥐 유래 대식세포(RAW264.7)에 대한 생존율을 확인한 결과, 5% 농도까지 세포 독성이 나타나지 않는 것을 확인할 수 있었다.As a result of checking the survival rate of HaCaT cells, which are human keratinocytes, and mouse-derived macrophages (RAW264.7) of the culture prepared through Preparation Example 3, it was confirmed that cytotoxicity did not appear up to a concentration of 5%. .

<실험예 2> Aquaporin-3 발현 증가 확인<Experimental Example 2> Confirmation of increased expression of Aquaporin-3

본 실험에서는 상기 제조예 3을 통해 제조된 배양물의 피부보습 관련 인자인 Aquaporin-3 발현을 확인하고자 하였다. 인간 각질형성세포(keratinocyte)인 HaCaT 세포를 이용하여 페니실린(penicillin, 100 IU/ml) 및 스트렙토마이신(streptomycin, 100 μg/ml)과 10%의 FBS를 함유하는 DMEM 배지를 이용하여 3×105 cells/ml 농도로 60 mm세포 배양 디쉬에서 24시간 전배양하였다. FBS를 함유하지 않는 DMEM 배지로 교체하고 시료를 24시간 동안 처리한 후 세포를 모아서 용해 버퍼를 넣어 세포를 용해하여 웨스턴 샘플을 얻어낸 뒤, 각 샘플 단백질 농도를 BSA를 표준으로 잡고 측정하였다. 이렇게 얻어진 값을 기준으로 단백질 농도가 되는 각 표본량을 가지고 Western blotting assay를 진행하였다. 먼저, SDS-PAGE를 실행하고 PVDF 막으로 단백질을 전달한 후 막을 5% skim milk를 사용하여 차단시켰다. 표적 단백질 항체 용액을 사용해 1차 처리하여 세척 후, 2차 항체 용액을 처리하고 다시 세척하였다. ECL 용액을 이용하여 발색시킨 뒤 Chemi-doc 장비를 이용하여 분석하였다.In this experiment, we attempted to confirm the expression of Aquaporin-3, a skin moisturizing factor, in the culture prepared through Preparation Example 3. Using HaCaT cells, which are human keratinocytes, 3 The cells were pre-cultured for 24 hours in a 60 mm cell culture dish at a concentration of cells/ml. After replacing with DMEM medium that does not contain FBS and treating the samples for 24 hours, cells were collected, lysis buffer was added to lyse the cells to obtain Western samples, and the protein concentration of each sample was measured using BSA as the standard. Western blotting assay was performed with each sample amount corresponding to protein concentration based on the value obtained in this way. First, SDS-PAGE was performed, proteins were transferred to a PVDF membrane, and the membrane was blocked using 5% skim milk. After primary treatment with a target protein antibody solution and washing, secondary treatment with an antibody solution and washing again. Color was developed using ECL solution and analyzed using Chemi-doc equipment.

도 1에 나타낸 것처럼, 본 발명의 제조예 3을 통해 제조된 배양물은 농도에 비례하게 Aquaporin-3 발현이 증가되는 것을 알 수 있었다.As shown in Figure 1, it was found that Aquaporin-3 expression was increased in the culture prepared through Preparation Example 3 of the present invention in proportion to the concentration.

<실험예 3> COX-2 생성 저해 효과 확인<Experimental Example 3> Confirmation of COX-2 production inhibition effect

본 실험에서는 상기 제조예 3을 통해 제조된 배양물의 염증 관련 인자인 COX-2 생성 저해 효과를 확인하고자 하였다. COX-2 생성 저해는 쥐 유래 대식세포(RAW264.7)를 6 well plate에 4.0×105 cell/well의 농도로 3 ml씩 분주한 다음 세포배양조건에서 24시간 안정화시켰다. 시료를 2 시간 전처리 후, 염증 유도 물질로 알려진 리포폴리사카라이드(LPS, Lipopolysaccharide)는 최종농도가 1 μg/ml이 되도록 처리하여 4시간 배양하였다. 배지를 제거한 다음에 세포를 배양용기로부터 떼어내어 단백질 분해효소 저해제(Proteaseinhibitor cocktail, Roche, USA)를 함유한 단백질 용출용액(CelLyticTM-MT Tissue Lysis Reagent, Sigma, USA)을 사용하여 균질화하였다. 추출액은 20분 동안 14000 rpm에서 원심분리한 뒤 상등액과 불용성 응집체를 분리하였다. 분리된 상등액의 단백질 농도는 바이오-라드 단백질 분석 키트(Bio-Rad protein assay kit, Bio-Rad, USA)를 이용하여 측정하였다. 또한, 상등액을 5×SDS(0.156M Tris-HCl, pH 6.8, 2.5% SDS, 37.5% 글리세롤, 37.5 mM DTT)와 1:4로 섞어 100℃에서 10분간 끓였다. 끓인 시료에서 40 ug 단백질을 SDS 4-12% SDS-PAGE 겔 분리하여 PVDF 막으로 옮겼다. 단백질이 옮겨진 막에서 단백질이 없는 부분을 탈지분유로 차단(blocking)시킨 다음, 1차 항체 및 2차 항체를 순차적으로 결합시킨 후, ECL 용액을 이용하여 발색시킨 뒤 Chemi-doc 장비를 이용하여 분석하였다.In this experiment, we sought to confirm the effect of inhibiting the production of COX-2, an inflammation-related factor, in the culture prepared through Preparation Example 3 above. To inhibit COX-2 production, mouse-derived macrophages (RAW264.7) were dispensed in 3 ml each at a concentration of 4.0 After pretreatment of the sample for 2 hours, lipopolysaccharide (LPS), known as an inflammation-inducing substance, was treated to a final concentration of 1 μg/ml and cultured for 4 hours. After removing the medium, the cells were removed from the culture vessel and homogenized using a protein elution solution (CelLyticTM-MT Tissue Lysis Reagent, Sigma, USA) containing a protease inhibitor cocktail (Roche, USA). The extract was centrifuged at 14000 rpm for 20 minutes, and then the supernatant and insoluble aggregates were separated. The protein concentration of the separated supernatant was measured using a Bio-Rad protein assay kit (Bio-Rad, USA). Additionally, the supernatant was mixed 1:4 with 5×SDS (0.156M Tris-HCl, pH 6.8, 2.5% SDS, 37.5% glycerol, 37.5 mM DTT) and boiled at 100°C for 10 minutes. 40 ug of protein from the boiled sample was separated on an SDS 4-12% SDS-PAGE gel and transferred to a PVDF membrane. The protein-free portion of the membrane to which the protein has been transferred is blocked with skim milk powder, followed by sequential binding of primary and secondary antibodies, color development using ECL solution, and analysis using Chemi-doc equipment. did.

도 2에 나타낸 것처럼, 본 발명의 제조예 3을 통해 제조된 배양물은 COX-2의 생성을 저해하는 것을 확인할 수 있었다.As shown in Figure 2, it was confirmed that the culture prepared through Preparation Example 3 of the present invention inhibited the production of COX-2.

<실험예 4> 피부 진정 효과에 대한 Clinical Test<Experimental Example 4> Clinical test for skin soothing effect

상기 실시예 1을 통해 제조된 화장료 조성물의 외부자극에 대한 피부 진정 효과에 대한 Clinical Test를 진행하고자 하였다. Clinical Test는 상기 실시예 1을 통해 제조된 화장료 조성물을 전완부에 세정 후 아침, 저녁으로 (1일 2회) 적당량 덜어 도포, 1일 2회 3일간 적용한 후에 분석하였다. 시험대상자는 시험 시작일 하루 전에 제외기준에 따라 선정된 시험대상자를 대상으로 시험부위를 세정하도록 한 후에 30분간 피부 안정을 취하고 사진촬영 및 기기평가(Spectrophotometer)를 실시하였다. 사진 촬영 및 기기평가 후 SLS(Sodium Lauryl Sulfate) 1.0%를 함침한 Chamber를 시험 부위에 24시간 동안 부착하였다. We attempted to conduct a clinical test on the skin soothing effect of the cosmetic composition prepared in Example 1 above against external stimulation. The clinical test was performed by applying an appropriate amount of the cosmetic composition prepared in Example 1 to the forearm in the morning and evening (twice a day) after washing it, and applying it twice a day for 3 days. The test subjects were selected according to the exclusion criteria one day before the start of the test. They were asked to clean the test area, then their skin was stabilized for 30 minutes, and photography and equipment evaluation (Spectrophotometer) were performed. After taking pictures and evaluating the device, a chamber impregnated with 1.0% SLS (Sodium Lauryl Sulfate) was attached to the test area for 24 hours.

시험당일에는 시험 부위에 부착된 Chamber를 제거한 후 시험 부위의 상태를 확인하였다. 홍반 유도가 잘 되었으면, 사진 촬영 및 기기평가를 실시하고, 홍반 유도가 부족하다고 판정이 되면 추가적으로 새로운 Chamber를 부착하며 추후에 시험 부위를 재확인 후 사진 촬영 및 기기 평가를 실시하였다, 측정을 끝낸 시험 대상자들에게 시험 제품의 사용법에 대해 설명하고 시험 제품을 배포하였다. 시험 24 내지 72시간 후에는 배포된 시험 시료를 사용 방법에 따라 사용한 시험 대상자를 대상으로 안전성 평가, 사진 촬영 및 기기 평가를 실시하여 효능을 평가하였다. On the day of the test, the chamber attached to the test area was removed and the condition of the test area was checked. If the erythema induction was successful, photography and device evaluation were performed. If it was determined that erythema induction was insufficient, a new chamber was additionally attached, and the test area was later rechecked and photography and device evaluation were performed. Test subjects who completed the measurement We explained to them how to use the test product and distributed the test product. 24 to 72 hours after the test, safety evaluation, photography, and device evaluation were conducted on test subjects who used the distributed test samples according to the usage method to evaluate efficacy.

평가를 위해서 시험 대상자는 항온·항습(22±2℃, RH40~60%) 조건의 대기실에서 30분 간 안정을 취하여 피부 표면 온도와 습도를 측정 공간의 환경에 적응하게 하였다, 객관적 측정을 위해 기기 평가는 연구자 1인이 매 측정시 동일한 부위를 측정하도록 하였다. 사진촬영은 Digital Cemera(SONY ILCE-5100, THAILAND)로 시험 부위를 촬영하였다. 표준화를 위하여 사진 촬영은 동일 연구자가 시행하였으며, 촬영 조건(세팅값 및 카메라의 높이)을 고정하였다. 기기는 색차계(Spectrophotometer CM-2600D, Minolta, Japan)를 사용하여 기기적 측정값(무차원 단위)을 적용하였으며, 구경은 8mm이다. 측정 변수인 *a value(Redness)는 측장값이 커질수록 피부 색이 붉어짐을 의미하며, 따라서 본 시험에서는 *a value의 측정값이 낮을수록 시험 제품의 진정(붉은기 완화) 효과가 있다고 평가하였다. For the evaluation, the test subject rested for 30 minutes in a waiting room with constant temperature and humidity (22±2℃, RH40~60%) to adapt the skin surface temperature and humidity to the environment of the measurement space. For objective measurement, the device was used. For the evaluation, one researcher measured the same area for each measurement. The test area was photographed with Digital Cemera (SONY ILCE-5100, THAILAND). For standardization, the photography was conducted by the same researcher, and the photography conditions (setting values and camera height) were fixed. Instrumental measurements (dimensionless units) were applied using a colorimeter (Spectrophotometer CM-2600D, Minolta, Japan), and the aperture was 8 mm. *a value (Redness), a measurement variable, means that the skin color becomes redder as the measurement value increases. Therefore, in this test, the lower the *a value measurement value, the more effective the test product is in soothing (relieving redness). .

피부자극평가는 시험 제품에 대해 이상반응인 홍반(Erythema), 부종(Edema), 인설(Scaling), 가려움(Itching), 자통(Stinging), 작열감(Burning), 뻣뻣함(Tightness), 따끔거림(Prickling)이나 다른 이상반응이 발생하는지의 존재 여부를 면밀히 관찰하고 피부이상반응이 나타날 시 심한 정도에 따라 등급을 표시하고 이에 대한 검사소견을 작성하였다. 방문하는 날이 아니더라도 시험에 더 이상 참가 할 수 없게 되는 경우는 본인의 서명이 첨부된 "시험참가 포기동의서"를 쓰도록 하였다.Skin irritation evaluation includes adverse reactions to test products such as erythema, edema, scaling, itching, stinging, burning, stiffness, and tingling. ) or other adverse reactions were closely observed, and when adverse skin reactions occurred, they were graded according to severity and test results were written. If you are no longer able to participate in the test even if it is not the day of your visit, you are asked to write a "Consent to Give Up Test Participation" with your signature attached.

이상 반응 여부 및 등급 분류표는 아래 표 1에 나타내었다.Adverse reactions and classification table are shown in Table 1 below.

도 3에 나타낸 것처럼 본 발명의 실시예 1을 통해 제조된 화장료 조성물의 외부 자극(SLS)에 의한 피부 진정(붉은기 완화) 효과를 평가한 결과, 72시간 이후에 11.3%가 완화(대조군은 3.2% 완화)되는 것을 알 수 있었다. As shown in Figure 3, as a result of evaluating the skin soothing (redness alleviation) effect caused by external stimulation (SLS) of the cosmetic composition prepared through Example 1 of the present invention, 11.3% was relieved after 72 hours (3.2% in the control group). % relief) was observed.

따라서, 본 발명에 따른 화장료 조성물은 녹차꽃에서 분리된 Saccharomyces cerevisiae J2K-23(KCTC 13695BP)와 누룩에서 분리된 Bacillus subtilis J2K-51(KCTC 14053BP)의 배양물이 함유되어 우수한 보습, 염증완화, 홍반개선 및 피부진정 효과를 나타내는 것으로 평가할 수 있었다. Therefore, the cosmetic composition according to the present invention contains cultures of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) isolated from yeast, and provides excellent moisturizing, inflammation relief, and erythema. It was evaluated as showing improvement and skin soothing effect.

<실시예 2> 본 발명 균주들을 이용한 폴리감마글루탐산 (Poly gamma glutamic acid: γ-PGA) 생산<Example 2> Production of poly gamma glutamic acid (γ-PGA) using strains of the present invention

본 실험에서는 본 발명의 균주인, 고초균과 효모를 이용하여 γ-PGA를 생산하고자 하였다. 그런데 고초균, 즉 바실러스 서브틸리스 (Bacillus subtilis)를 배양하면 특유의 악취가 발생하는 문제가 있다. 본 실험에서는 악취가 나오지 않으면서도 γ-PGA를 고수율로 생산할 수 있는 방법을 개발해 보고자 하였다. In this experiment, we attempted to produce γ-PGA using Bacillus subtilis and yeast, which are strains of the present invention. However, when cultivating Bacillus subtilis, that is, Bacillus subtilis, there is a problem in that a unique odor is generated. In this experiment, we attempted to develop a method that can produce γ-PGA in high yield without producing bad odor.

실험을 위해, 배지에 Yeast Extract(Y.E) 대신 Malt Extrac(M.E)를 넣고, 본 발명 균주들의 혼합배양을 진행하면서, γ-PGA 생산량 및 악취 감소 여부를 관찰하였다. 혼합배양은, 포도당 10g/L, 질소원(Y.E or M.E) 10g/L, 소듐글루타메이트 10g/L, 제이인산칼륨 0.5g/L, 황산마그네슘7수화물 0.1g/L으로 조성된 배지를 이용하였고, 상기 제조예 3에 기재된 방법에 준해 수행하였다. For the experiment, Malt Extract (M.E) was added to the medium instead of Yeast Extract (Y.E), and while mixed culture of the strains of the present invention was performed, γ-PGA production and odor reduction were observed. For mixed culture, a medium composed of 10 g/L of glucose, 10 g/L of nitrogen source (Y.E or M.E), 10 g/L of sodium glutamate, 0.5 g/L of potassium phosphate, and 0.1 g/L of magnesium sulfate heptahydrate was used. It was performed according to the method described in Preparation Example 3.

구분division 균주strain Yeast ExtractYeast Extract Malt ExtractMalt Extract 특이취1) Unusual taste 1) γ-PGA 생성량(%)γ-PGA production amount (%) 대조군 1Control group 1 J2K-23J2K-23 OO XX 1One -- 대조군 2Control group 2 J2K-23J2K-23 XX OO 1One -- 대조군 3Control group 3 J2K-51J2K-51 OO XX 44 3.23.2 대조군 4Control group 4 J2K-51J2K-51 XX OO 33 2.42.4 실험군 1Experimental group 1 J2K-23
J2K-51
J2K-23
J2K-51
OO XX 44 2.72.7
실험군 2Experimental group 2 J2K-23
J2K-51
J2K-23
J2K-51
XX OO 22 2.92.9

주 1) 특이취: 4(매우강함), 3(강함), 2(보통), 1(약함), 0(무취).Note 1) Specific odor: 4 (very strong), 3 (strong), 2 (average), 1 (weak), 0 (odorless).

대조군 1, 2의 경우, 즉 S. cerevisiae J2K-23만 배양할 경우는 γ-PGA가 생성되지 않았다. 또한, 대조군 3, 4의 경우, B. subtilis J2K-51만 배양할 경우는 γ-PGA가 생성되어 배양액에 점도가 형성되었지만, 배양액에서 특이취가 심하게 발생하였다. In the case of control groups 1 and 2, that is, when only S. cerevisiae J2K-23 was cultured, γ-PGA was not produced. In addition, in the case of control groups 3 and 4, when only B. subtilis J2K-51 was cultured, γ-PGA was produced and viscosity was formed in the culture medium, but a strong specific odor occurred in the culture medium.

그리고, Malt Extract(M.E)를 이용하여 배양할 경우(대조군 4)가, Yeast Extract를 사용한 배양 (대조군 3)에 비해 악취가 감소하는 것으로 나타났으나, 배양액의 점도와 γ-PGA의 수율이 Yeast Extract를 사용하는 경우(대조군 3)에 비해 많이 낮아지는 것(3.2%->2.4%)으로 확인되었다. In addition, when culturing using Malt Extract (M.E) (Control Group 4), the odor was found to be reduced compared to culturing using Yeast Extract (Control Group 3), but the viscosity of the culture medium and the yield of γ-PGA were lower than those of Yeast Extract (Control Group 4). It was confirmed that it was significantly lower (3.2% -> 2.4%) compared to when Extract was used (Control Group 3).

한편, Y.E(Yeast Extract)를 이용하여 혼합발효를 진행한 실험군 1의 경우, 악취는 대조군들과 크게 차이가 없었고, J2K-51번을 단독 배양한 대조군보다 γ-PGA 생성량이 낮은 수율을 나타낸 것으로 확인되었다. Meanwhile, in the case of experimental group 1, where mixed fermentation was performed using Y.E (Yeast Extract), the odor was not significantly different from the control group, and the yield of γ-PGA was lower than that of the control group in which J2K-51 was cultured alone. Confirmed.

그런데, M.E를 이용하여 혼합발효를 진행한 실험군 2의 경우, J2K-51번을 단독 배양한 대조군보다 γ-PGA 생성량은 조금 적게 생성되지만, 특유의 악취가 현저히 개선된 것으로 확인되었다. 이를 통해, 효모 균주의 혼합 배양이 악취 제거에 탁월한 효과를 발휘한다는 것을 확인할 수 있었다. However, in the case of experimental group 2, where mixed fermentation was performed using M.E., slightly less γ-PGA was produced than the control group in which J2K-51 was cultured alone, but the unique odor was confirmed to be significantly improved. Through this, it was confirmed that the mixed culture of yeast strains is excellent for removing bad odors.

<실시예 3> γ-PGA의 생산 수율을 높일 수 있는 배지 조성 개발<Example 3> Development of a medium composition that can increase the production yield of γ-PGA

상기 실시예 2를 통해, Malt Extract(M.E)를 사용하여 혼합배양을 하면, 악취가 제거되면서도, 비교적 고수율로 γ-PGA를 생산할 수 있음을 확인하였다. Through Example 2, it was confirmed that when mixed culture was performed using Malt Extract (M.E), γ-PGA could be produced at a relatively high yield while eliminating bad odor.

하지만, 본 실험에서는 보다 높은 수율로 γ-PGA를 생산할 수 있는 최적 배지 조성을 탐구해 보고자 하였다. 하기 표 3은 최적 배지 조성을 확인하기 위해 설계한 배지 조성이다. 다만, 미량원소(제이인산칼륨 0.5g/L, 황산마그네슘7수화물 0.1g/L)는 모두 동일하게 투입하였다. 하기 표 3에서 대조군은 고초균 J2K-51만 접종한 것이고, 실험군은 고초균인 J2K-51과 효모균인 J2K-23를 혼합배양한 것이다. However, in this experiment, we attempted to explore the optimal medium composition that can produce γ-PGA with higher yield. Table 3 below shows the medium composition designed to confirm the optimal medium composition. However, all trace elements (0.5 g/L of potassium phosphate, 0.1 g/L of magnesium sulfate heptahydrate) were added in the same way. In Table 3 below, the control group was inoculated with only Bacillus subtilis J2K-51, and the experimental group was a mixed culture of Bacillus subtilis J2K-51 and yeast J2K-23.

구분division GlucoseGlucose Malt ExtractMalt Extract Sodium
glutamate
Sodium
glutamate
특이취1) Unusual taste 1) r-PGA 생성량(%)r-PGA production amount (%)
대조군4Control group 4 1010 1010 1010 33 2.42.4 실험군2Experimental group 2 1010 1010 1010 22 2.92.9 실험군3Experimental group 3 2020 1010 1010 22 3.63.6 실험군4Experimental group 4 4040 1010 1010 33 3.53.5 실험군5Experimental group 5 1010 55 1010 1One 2.42.4 실험군6Experimental group 6 1010 2020 1010 33 3.43.4 실험군7Experimental group 7 1010 4040 1010 44 3.83.8 실험군8Experimental group 8 1010 1010 3030 22 4.44.4 실험군9Experimental group 9 1010 1010 5050 33 5.45.4 실험군10Experimental group 10 1010 1010 7070 44 5.05.0 대조군5Control group 5 2020 55 5050 44 5.75.7 실험군11Experimental group 11 2020 55 5050 22 5.65.6

주 1) 특이취: 4(매우강함), 3(강함), 2(보통), 1(약함), 0(무취) Note 1) Specific odor: 4 (very strong), 3 (strong), 2 (average), 1 (weak), 0 (odorless)

실험 결과, 포도당 20g/L, Malt Extract 5g/L, 소듐글루타메이트 50g/L, 제이인산칼륨 0.5g/L, 황산마그네슘7수화물 0.1g/L의 배지조건 (실험군 11)에서, 효모균 J2K-23 및 고초균 J2K-51의 혼합배양을 통해, 고초균 J2K-51 단일 배양보다 특이취가 적은 γ-PGA 함유 배양물을 고수율로 얻을 수 있었다.As a result of the experiment, under medium conditions (experimental group 11) of glucose 20g/L, malt extract 5g/L, sodium glutamate 50g/L, dipotassium phosphate 0.5g/L, and magnesium sulfate heptahydrate 0.1g/L, yeast J2K-23 and Through mixed culture of Bacillus subtilis J2K-51, a γ-PGA-containing culture with less specific odor than Bacillus subtilis J2K-51 single culture could be obtained in high yield.

이상과 같이, Yeast Extract(Y.E) 대신 Malt Extract(M.E)를 사용하고, J2K-23 및 J2K-51의 혼합배양을 통해 γ-PGA를 고수율로 생산할 수 있었으며, 특유의 악취가 감소되어 정제공정을 단순화 할 수 있음을 확인할 수 있었다. 악취 제거를 위해서는 일반적으로 용매침전 후 침전물을 회수, 재용해하는 부수적인 공정이 필요한데, 본 발명에서는 이러한 부수적인 공정이 불필요하여 경제적이고, 친환경적인 것이다. As above, γ-PGA could be produced in high yield by using Malt Extract (M.E) instead of Yeast Extract (Y.E) and mixed culture of J2K-23 and J2K-51, and the unique odor was reduced, improving the purification process. It was confirmed that it can be simplified. In order to remove odor, an additional process of recovering and re-dissolving the precipitate after solvent precipitation is generally required, but in the present invention, this additional process is unnecessary, making it economical and environmentally friendly.

한국생명공학연구원 생물자원센터(KCTC)Korea Research Institute of Bioscience and Biotechnology Biological Resources Center (KCTC) KCTC13695BPKCTC13695BP 2018103120181031 한국생명공학연구원 생물자원센터(KCTC)Korea Research Institute of Bioscience and Biotechnology Biological Resources Center (KCTC) KCTC14053BPKCTC14053BP 2019120220191202

Claims (6)

녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 혼합배양하여 수득되는 배양액을 함유하며,
상기 배양액은 포도당 10~30g/L, 맥아 추출물 (Malt Extract) 1~9g/L 및 소듐글루타메이트 25~75g/L를 포함하는 배양 배지에서 혼합 배양되어 폴리감마글루탐산(poly-gamma-glutamic acid; γ-PGA)을 함유하며 배양 악취가 저감된 것을 특징으로 하는 피부자극 완화용 화장료 조성물.
Obtained by mixed culture of Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast. Contains a culture medium that
The culture medium was mixed and cultured in a culture medium containing 10 to 30 g/L of glucose, 1 to 9 g/L of malt extract, and 25 to 75 g/L of sodium glutamate to produce poly-gamma-glutamic acid (γ). -PGA) and a cosmetic composition for alleviating skin irritation, characterized by reduced culture odor.
상기 제1항에 있어서,
상기 화장료 조성물은,
피부보습능, 염증완화능, 홍반개선능 및 피부진정능 중 선택되는 어느 하나의 효능이 더 있는 것을 특징으로 하는 피부자극 완화용 조성물.
According to paragraph 1 above,
The cosmetic composition is,
A composition for relieving skin irritation, characterized in that it further has any one effect selected from skin moisturizing effect, inflammation alleviating effect, erythema improving effect, and skin soothing effect.
녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 포도당 10~30g/L, 맥아 추출물 (Malt Extract) 1~9g/L 및 소듐글루타메이트 25~75g/L를 포함하는 배양 배지에서 혼합배양하며, 배양 악취가 저감된 것을 특징으로 하는 폴리감마글루탐산(poly-gamma-glutamic acid; γ-PGA)의 생산방법.
Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast with 10 to 30 g of glucose. /L, mixed culture in a culture medium containing 1 to 9 g/L of malt extract and 25 to 75 g/L of sodium glutamate, and poly-gamma-glutamic acid characterized by reduced culture odor. Method for producing acid; γ-PGA).
삭제delete 녹차꽃에서 분리된 사카로마이세스 세레비지애 (Saccharomyces cerevisiae) J2K-23(KCTC 13695BP) 균주와 누룩에서 분리된 바실러스 서브틸리스 (Bacillus subtilis) J2K-51(KCTC 14053BP) 균주를 포도당 10~30g/L, 맥아 추출물 (Malt Extract) 1~9g/L 및 소듐글루타메이트 25~75g/L를 포함하는 배양 배지에서 혼합배양하며, 배양 악취가 저감된 것을 특징으로 하는 폴리감마글루탐산(poly-gamma-glutamic acid; γ-PGA) 함유 배양액의 제조방법. Saccharomyces cerevisiae J2K-23 (KCTC 13695BP) strain isolated from green tea flowers and Bacillus subtilis J2K-51 (KCTC 14053BP) strain isolated from yeast with 10 to 30 g of glucose. /L, mixed culture in a culture medium containing 1 to 9 g/L of malt extract and 25 to 75 g/L of sodium glutamate, and poly-gamma-glutamic acid characterized by reduced culture odor. Method for producing culture medium containing acid; γ-PGA). 삭제delete
KR1020230018937A 2023-02-13 2023-02-13 Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP) KR102588606B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020230018937A KR102588606B1 (en) 2023-02-13 2023-02-13 Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020230018937A KR102588606B1 (en) 2023-02-13 2023-02-13 Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)

Publications (1)

Publication Number Publication Date
KR102588606B1 true KR102588606B1 (en) 2023-10-13

Family

ID=88289742

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020230018937A KR102588606B1 (en) 2023-02-13 2023-02-13 Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)

Country Status (1)

Country Link
KR (1) KR102588606B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005015347A (en) * 2003-06-23 2005-01-20 Ichimaru Pharcos Co Ltd Filaggrin synthesis promoter
KR100517114B1 (en) 2005-02-25 2005-09-27 주식회사 바이오리더스 Composition for adjuvant containing poly-gamma-glutamic acid
KR101824179B1 (en) 2016-04-06 2018-01-31 이스트힐(주) Cosmetic composition for moisturizing and anti-inflammatory effect having fermented artemisia gmelinii weber ex stechm.
KR102293081B1 (en) 2019-10-21 2021-08-26 (주) 나우코스 Cosmetic composition for skin moisturizing comprising Mixed extract of Moutan radiciscortex and fermentation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005015347A (en) * 2003-06-23 2005-01-20 Ichimaru Pharcos Co Ltd Filaggrin synthesis promoter
KR100517114B1 (en) 2005-02-25 2005-09-27 주식회사 바이오리더스 Composition for adjuvant containing poly-gamma-glutamic acid
KR101824179B1 (en) 2016-04-06 2018-01-31 이스트힐(주) Cosmetic composition for moisturizing and anti-inflammatory effect having fermented artemisia gmelinii weber ex stechm.
KR102293081B1 (en) 2019-10-21 2021-08-26 (주) 나우코스 Cosmetic composition for skin moisturizing comprising Mixed extract of Moutan radiciscortex and fermentation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
네이버 블로그, "올바른 화장품 선택. 성분과 효능/효과 알아봐요~"(2021.04.08.) 1부.* *
한국경제TV 인터넷 뉴스, "J2KBIO, 고기능 화장품 원료 ‘Metabiome HK-503’ 개발", 한국경제TV 인터넷 뉴스(2020.12.02.) 1부.* *

Similar Documents

Publication Publication Date Title
KR20200096807A (en) Probiotic composition and use thereof
KR102156898B1 (en) Ingestible cosmetic composition for skin whitening, skin moisturizing, antioxidant, anti-inflammatory, skin barrier strengthening and skin absorption containing the lactic acid fermentation mixture
KR101685581B1 (en) Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom
KR102119825B1 (en) A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof
KR101770140B1 (en) Lactobacillus fermentum HK and Phormium tenax Fermented extract Manufactured Using Thereof
CN109715183A (en) The new beauty and make-up and/or nutrition and health care or dermatological use of yeast extract
KR102125316B1 (en) cosmetic composition for anti-irritation and skin soothing using Lactobacillus pentosus J2K-185strain
KR102174260B1 (en) Cosmetic composition containing complex ferment extract of Ixeris dentata nakai, Inula flower And Dandelion
US20180140646A1 (en) Fermented composition for relieving atopic dermatitis containing natural extracts
KR20170143053A (en) Cosmetic composition for improving anti-oxidation, anti-wrinkle and moisturizing comprising fermented product of used water from washing rice and preparation method of the same
KR101810141B1 (en) Lactobacillus plantarum HK and Telopea speciosissima Fermented extract Manufactured Using Thereof
KR102588606B1 (en) Method for the production of cosmetic composition and γ-PGA by mixed culture of Saccharomyces cerevisiae J2K-23(KCTC 13695BP) and Bacillus subtilis J2K-51(KCTC 14053BP)
KR102140139B1 (en) Skin derived novel lactic acid bacteria and cosmetic composition comprising thereof
KR101796494B1 (en) Lactobacillus pentosus-GFC LP
KR20180038681A (en) Cosmetic Composition Containing the Mixed Extract of Black Currant Fruit and Aronia Melanocarpa Fruit
KR101578908B1 (en) Extract of fermentative Zizyphus jujuba Fructus by Laetiporus sulphureus having lifespan extention of C. elegans via stress response and increasing collegen synthesis, and its cosmetic and therapeutic agent for wrinkle containing the same
KR101970628B1 (en) Cosmetic Composition Containing Extracts of Blackberry and Cranberry
KR101908976B1 (en) A cosmetic composition containing lactobacillus-fermented extract for improving atopic dermatitis
KR101817776B1 (en) Lespedeza cuneata G.Don Fermented extract Using Lactobacillus pentosus-GFC LP and Method for Preparing the Same
KR101951646B1 (en) A cosmetic composition comprising marinobacter-fermented spirulina extract for antioxydant and skin winkle improvement
CN115666509A (en) Fermented nano-emulsifier composition and method for producing same
KR102098695B1 (en) Cosmetic Composition Containing Extracts of Morus Alba Root and Paeonia Suffruticosa Root
KR20160122379A (en) Manufacture method of fermented complex using dongchimi materials and cosmetic composition using by the method and cosmetic comprising the cosmetic composition
KR20200087015A (en) Fermented composition of ice plant and collagen for anti-aging and anti-wrinkle, method for preparing the same and cosmetic composition comprising the same
KR102093879B1 (en) The cosmetic composition containing root extract of Adenophora stricta for improving skin wrinkle

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant